Melissa Clague

Melissa Clague is currently a Senior Director in Bioproduct Pharmaceutical Research and Development at Eli Lilly & Company.

She joined Bioproduct Development in 2002, where she developed the analytical control strategy for a half-dozen antibodies and several other bioproducts. She has been instrumental in developing the analytical tools, vendor relationships and business processes to advance the early-phase portfolio.

Prior to working in Bioproduct Development, she worked at Lilly in Infectious Diseases Discovery Research, where she developed kinetically sound biochemical assays for high-throughput screening for several antimicrobial targets.

Melissa Clague earned a B.S. in Chemistry from Yale University, an M.A. and a Ph.D. from UC, Santa Barbara, in inorganic chemistry, laboratory of Alison Butler: Modelling Vanadium Bromoperoxidase: Vanadium Catalysts for the Oxidation of Bromide by Hydrogen Peroxide. She completed her studies at the University of Michigan as a post-doctoral fellow in the laboratory of Michael A. Marletta: Metal Substitution of Nitric Oxide Synthase: Catalytic Properties of the New Enzymes and Implications for the Mechanism of NO Biosynthesis.